Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mastercard Inc (MA) Accused By EU Officials Of Artificially Raising Card Payments Costs

Page 1 of 2

Mastercard Inc (NYSE:MA) has been hit by a strongly-worded allegation from European Union officials that they think the financial giant is fleecing customers with inflated fees. In a statement, the European Commission, the highest executive body of the European Union, says that they “currently suspect MasterCard is artificially raising the costs of card payments”. According to Commissioner Margrethe Vestager, the European Commission chief who is infamous for taking on Google, the practice is harming consumers and retailers in the European Union. More specifically, the commission has concerns with the rules MasterCard applies to cross-border transactions within the European Union and the fees charged to retailers for receiving payments made with cards issued outside Europe. The commission says that this is a chance for MasterCard to respond to their charges. In a statement to the BBC, however, MasterCard says that it is working with the European Commission on the issue while also preparing a formal response to the European Commission’s release.

Mastercard Inc (MA), NYSE:MA,

The allegations about Mastercard Inc (NYSE:MA) comes as it also experienced a decline in confidence from the world’s best money managers by the end of the first quarter. let’s take a look at the latest action regarding Mastercard Inc. At the end of the first quarter, a total of 83 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -9% from the previous quarter. The overall value of holdings held by those still long in MasterCard by the end of March also decreased to $7.63 billion, down 8.83% from $8.37 billion in the prior quarter, even though the stock’s price experienced a marginal increase of 0.27% in the first three months of the year.

Hedge funds and other big money managers tend to have the largest amounts of their capital invested in large and mega-cap stocks like Mastercard Inc (NYSE:MA) because these companies allow for much greater capital allocation. That’s why if we take a look at the most popular stocks among funds, we won’t find many mid- or small-cap stocks there. However, our backtests of hedge funds’ equity portfolios between 1999 and 2012 revealed that the 50 most popular stocks among hedge funds underperformed the market by seven basis points per month, showing that their most popular picks and the ones that received the bulk of their capital were not actually their best picks. On the other hand, their top small-cap picks performed considerably better, outperforming the market by 95 basis points per month. This was confirmed through backtesting and in forward tests of our small-cap strategy since August 2012. The strategy, which involves imitating the 15 most popular small-cap picks among hedge funds has provided gains of more than 135%, beating the broader market by over 80 percentage points through the end of June (see the details).

Insider Monkey also evaluates insider transactions to gauge whether insider purchases or sales of shares indicate a significant bullish or bearish sentiment from company insiders about their own firms. In the case of MasterCard, there were no open market purchases of shares made yet by insiders this year while there have been sales. The most recent sale was by General Counsel Timothy Murphy on Monday, July 6, totaling 3,964 shares. CEO Ajay Banga also sold 99,870 shares at the start of May. Keeping these in mind, let us examine how hedge funds have traded MasterCard lately on the next page.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!